Koninklijke Philips NV ADR
$ 29.70
3.74%
17 Apr - close price
- Market Cap 28,471,595,000 USD
- Current Price $ 29.70
- High / Low $ 29.95 / 29.59
- Stock P/E 27.00
- Book Value 13.59
- EPS 1.10
- Next Earning Report 2026-05-05
- Dividend Per Share $0.85
- Dividend Yield 3.41 %
- Next Dividend Date 2026-06-03
- ROA 0.03 %
- ROE 0.08 %
- 52 Week High 33.44
- 52 Week Low 21.95
About
Koninklijke Philips NV is a healthcare technology company in North America, Greater China and internationally. The company is headquartered in Amsterdam, the Netherlands.
Analyst Target Price
$33.74
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-10 | 2025-11-04 | 2025-07-28 | 2025-04-28 | 2025-02-19 | 2024-10-28 | 2024-07-29 | 2024-04-29 | 2024-01-29 | 2023-10-23 | 2023-07-24 | 2023-04-24 |
| Reported EPS | 0.7141 | 0.36 | 0.2846 | 0.2832 | 0.51 | 0.32 | 0.3 | 0.26 | 0.41 | 0.33 | 0.28 | 0.22 |
| Estimated EPS | 0.5365 | 0.3697 | 0.3174 | 0.1449 | 0.6 | 0.35 | 0.25 | 0.26 | 0.57 | 0.32 | 0.3 | 0.14 |
| Surprise | 0.1776 | -0.0097 | -0.0328 | 0.1383 | -0.09 | -0.03 | 0.05 | 0 | -0.16 | 0.01 | -0.02 | 0.08 |
| Surprise Percentage | 33.1034% | -2.6237% | -10.334% | 95.4451% | -15% | -8.5714% | 20% | 0% | -28.0702% | 3.125% | -6.6667% | 57.1429% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-05 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.23 |
| Currency | USD |
Previous Dividend Records
| Jun 2026 | Jun 2025 | Jun 2022 | Jun 2021 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-06-03 | 2025-06-06 | 2022-06-08 | 2021-06-09 | None | None | None | None | None | None |
| Amount | $1.01303 | $0.88604 | $0.964112 | $1.033107 | $0.960117 | $0.991704 | $0.762926 | $0.766224 | $0.759016 | $0.925548 |
Next Dividend Records
| Dividend per share (year): | $0.85 |
| Dividend Yield | 3.41% |
| Next Dividend Date | 2026-06-03 |
| Ex-Dividend Date | 2026-05-13 |
Recent News: PHG
2026-04-16 21:40:20
This article provides the dividend calendar for Koninklijke Philips N.V., detailing an announced dividend of EUR 0.85 per share for the full year 2024, payable on June 6, 2025. It also includes recent news updates related to Philips, covering FDA clearance for AI-powered CT, CEO re-appointment proposals, and quarterly financial results.
2026-04-16 12:39:07
Philips has received FDA 510(k) clearance for its Spectral CT Verida system, an AI-powered detector-based spectral CT. This system integrates AI reconstruction with always-on spectral imaging to enhance image quality, efficiency, and clinical insights across various medical applications, including radiology, cardiology, and oncology. Verida aims to support faster, more informed decisions and expand the utility of CT imaging.
2026-04-16 12:39:07
Royal Philips has received FDA 510(k) clearance for its Spectral CT Verida system, an AI-powered, detector-based spectral CT that can complete full exams in under 30 seconds and reconstructs 145 images per second. This technology is designed to enhance diagnostic precision across radiology, interventional radiology, cardiology, and oncology. The Verida system features always-on spectral imaging without requiring separate scans, improving workflow efficiency for medical professionals.
2026-04-15 10:29:41
Koninklijke Philips is prioritizing growth in diagnostics, image-guided therapy, and AI-driven health solutions, moving beyond consumer electronics to focus on connected care ecosystems. The company's strategy aligns with rising healthcare spending driven by demographics and technological adoption, with a strong emphasis on integrating AI algorithms for improved patient outcomes and operational efficiency. Philips aims for mid-single-digit comparable sales growth and strong operating margins, backed by significant R&D investments and a commitment to shareholder returns.
2026-04-15 08:10:28
Koninklijke Philips N.V. is transitioning from consumer electronics to a health technology leader, focusing on connected care solutions across diagnosis, treatment, and personal health. This strategy, driven by healthcare digitization and an aging global population, aims for sustainable growth through software-enabled devices, recurring revenue, and outcome-based partnerships. Investors should consider Philips' strong competitive position and R&D spending, while also monitoring regulatory risks from past recalls and supply chain challenges.
2026-04-15 04:40:45
Koninklijke Philips N.V. has strategically shifted its focus to health technology, emphasizing connected diagnostics and patient monitoring, which aligns well with U.S. healthcare spending priorities. This transformation positions the company to capitalize on booming healthcare trends, providing investors with exposure to resilient growth without significant domestic risks. Despite potential litigation and supply chain risks, Philips' R&D investments and integrated platforms offer strong competitive advantages and long-term value in the digital health sector.
